TY - JOUR
T1 - Impact of differential right-to-left shunting on systemic perfusion in pulmonary arterial hypertension
AU - Weimar, Timo
AU - Watanabe, Yoshiyuki
AU - Kazui, Toshinobu
AU - Lee, Urvi S.
AU - Montecalvo, Alessandro
AU - Schuessler, Richard B.
AU - Moon, Marc R.
PY - 2013/4
Y1 - 2013/4
N2 - Objectives: This study aimed at identifying the ideal right-to-left shunt-fraction to improve cardiac output (CO) and systemic perfusion in pulmonary arterial hypertension (PHT). Background: Atrial septostomy (AS) has been a high-risk therapeutic option for symptomatic drug-refractory patients with PHT. Results have been unpredictable due to limited knowledge of the optimal shunt-quantity. Methods: In nine dogs, an 8-mm shunt-prosthesis was inserted between the superior vena cava (SVC) and the left atrium. With pulmonary artery (PA) banding, mean (6SEM) systolic right ventricular pressure increased from 37 ± 1 mm Hg at baseline to 44 ± 1 mm Hg (moderate PHT, P 5 0.005) and 50 ± 2 mm Hg (severe PHT, P < 0.001). Shunt-flow was adjusted by total (forcing all flow through the shunt) or partial occlusion of the SVC and partial or total clamping of the shunt. Caval-, shunt-, and aortic-flow were measured by ultrasonic flow-probes. Blood gases were drawn from the aortic root and PA. Results: At severe PHT, a shunt-flow of 11 ± 1% of CO (253 ± 90 mL/min) increased CO significantly by 25% (1.8 ± 0.1 to 2.4 ± 0.2 L/min, P = 0.005) causing an increase of systemic oxygen delivery index (DO2I) by 23% (309 ± 23 to 399 ± 32 mL/min/m 2, P = 0.035). Arterial O2- saturation did not change significantly until a shunt-flow of 18 ± 2% was exceeded, causing a drop from 96 ± 1% to 84 ± 4% (P = 0.013). At moderate PHT, CO or DO2I did not improve significantly at any shunt-flow. Conclusions: In severe PHT, a shuntflow of 11% of CO represented the ideal shunt-fraction. Augmentation of CO compensated for declined O2-saturation due to right-to-left shunting and improved DO2I. In moderate PHT, AS is less promising.
AB - Objectives: This study aimed at identifying the ideal right-to-left shunt-fraction to improve cardiac output (CO) and systemic perfusion in pulmonary arterial hypertension (PHT). Background: Atrial septostomy (AS) has been a high-risk therapeutic option for symptomatic drug-refractory patients with PHT. Results have been unpredictable due to limited knowledge of the optimal shunt-quantity. Methods: In nine dogs, an 8-mm shunt-prosthesis was inserted between the superior vena cava (SVC) and the left atrium. With pulmonary artery (PA) banding, mean (6SEM) systolic right ventricular pressure increased from 37 ± 1 mm Hg at baseline to 44 ± 1 mm Hg (moderate PHT, P 5 0.005) and 50 ± 2 mm Hg (severe PHT, P < 0.001). Shunt-flow was adjusted by total (forcing all flow through the shunt) or partial occlusion of the SVC and partial or total clamping of the shunt. Caval-, shunt-, and aortic-flow were measured by ultrasonic flow-probes. Blood gases were drawn from the aortic root and PA. Results: At severe PHT, a shunt-flow of 11 ± 1% of CO (253 ± 90 mL/min) increased CO significantly by 25% (1.8 ± 0.1 to 2.4 ± 0.2 L/min, P = 0.005) causing an increase of systemic oxygen delivery index (DO2I) by 23% (309 ± 23 to 399 ± 32 mL/min/m 2, P = 0.035). Arterial O2- saturation did not change significantly until a shunt-flow of 18 ± 2% was exceeded, causing a drop from 96 ± 1% to 84 ± 4% (P = 0.013). At moderate PHT, CO or DO2I did not improve significantly at any shunt-flow. Conclusions: In severe PHT, a shuntflow of 11% of CO represented the ideal shunt-fraction. Augmentation of CO compensated for declined O2-saturation due to right-to-left shunting and improved DO2I. In moderate PHT, AS is less promising.
KW - Atrial septostomy
KW - Cardiac output
KW - Oxygen delivery
KW - Shunt
UR - http://www.scopus.com/inward/record.url?scp=84884197442&partnerID=8YFLogxK
U2 - 10.1002/ccd.24458
DO - 10.1002/ccd.24458
M3 - Article
C2 - 22511538
AN - SCOPUS:84884197442
SN - 1522-1946
VL - 81
SP - 888
EP - 895
JO - Catheterization and Cardiovascular Interventions
JF - Catheterization and Cardiovascular Interventions
IS - 5
ER -